Prophylactic human papillomavirus vaccination: from the origin to the current state

A Akhatova, A Azizan, K Atageldiyeva… - Vaccines, 2022 - mdpi.com
… However, HPV vaccination dread, concerns about its safety, and associated adverse … on
the HPV vaccine implementation campaigns all over the world. Many developed countries have …

Human papillomavirus vaccination in low-and middle-income countries: progression, barriers, and future prospective

N Ebrahimi, Z Yousefi, G Khosravi, FE Malayeri… - Frontiers in …, 2023 - frontiersin.org
countries that use these vaccination programs has increased each month. Millions of girls in
developing countries … -income countries could be a helpful roadmap for developing nations (…

Estimate of global human papillomavirus vaccination coverage: analysis of country-level indicators

J Spayne, T Hesketh - BMJ open, 2021 - bmjopen.bmj.com
… . Cervical cancer in developing countries: effective screening and preventive strategies
with an application in Rwanda. Health Care Women Int 2014;35:1065–80.doi:10.1080/…

Human papillomavirus vaccine efficacy and effectiveness against cancer

S Kamolratanakul, P Pitisuttithum - Vaccines, 2021 - mdpi.com
… , especially in developing countries. Three HPV … vaccination strategies in any country should
be temporarily postponed until all countries have been able to introduce HPV vaccination in …

Human papillomavirus vaccination and cervical cancer risk

L Rahangdale, C Mungo, S O'Connor, CJ Chibwesha… - Bmj, 2022 - bmj.com
countries.Less than 25% of low income countries have human papillomavirus vaccination as
… Most gaps in the introduction and coverage of human papillomavirus vaccine are in regions …

Barriers to and facilitators of human papillomavirus vaccination among people aged 9 to 26 years: a systematic review

L Zheng, J Wu, M Zheng - Sexually transmitted diseases, 2021 - journals.lww.com
papillomavirus vaccine implementation, a major obstacle to human papillomavirus vaccination
is … 42s The main source of HPV vaccination program costs in developed countries is the …

Human papillomavirus vaccines: an updated review

L Cheng, Y Wang, J Du - Vaccines, 2020 - mdpi.com
… Population-level impact and herd effects following the introduction of human papillomavirus
vaccination programmes: Updated systematic review and meta-analysis. Lancet 2019, 394, …

Progress in vaccination of prophylactic human papillomavirus vaccine

X Zhou, L Sun, X Yao, G Li, Y Wang, Y Lin - Frontiers in Immunology, 2020 - frontiersin.org
… However, in most highly developed countries, vaccine coverage has not reached effective
… The role of human papillomavirus vaccines in cervical cancer: prevention and treatment. Crit …

Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis

T Dorji, T Nopsopon, ST Tamang, K Pongpirul - EClinicalMedicine, 2021 - thelancet.com
… HPV vaccine in each country and total samples in each country with an associated 95%
confidence interval (CI). The secondary outcomes were the types of vaccines used, vaccination

Human papillomavirus vaccination

LE Markowitz, ER Unger - New England Journal of Medicine, 2023 - Mass Medical Soc
vaccination account for approximately 90% of HPV-attributable cancers worldwide. Other
HPV vaccines have been developed … women in Nordic countries who had been vaccinated in …